Antimicrobial susceptibility testing of Arcobacter butzleri and Arcobacter cryaerophilus isolated from buffalo milk with subclinical mastitis: A different approach
Résumé
The aim of our study was the minimum inhibitory concentrations (MICs) of 9 antimicrobials in current use and 3 potentially new alternatives against Arcobacter spp. isolated from dairy buffaloes with subclinical mastitis, and to evaluate these parameters together with pharmacokinetic parameters. The Arcobacter isolates was isolated from milk samples collected from dairy buffaloes with subclinical mastitis. The susceptibility of Arcobacter strains to antimicrobials were determined with the NCCLS microdilution technique and, not seen the blur according to the recommendations at the lowest concentration of antibiotic. MIC value of vancomycin, erythromycin and tetracycline were not determined, and MIC value of ceftiofur, spiramycin and gentamicin have showed wide variations for isolated strains. However, cefquinome, tylosin, enrofloxacin and florfenicol were determined the best-performing agents against these strains. Antibiotics show concentration and time dependent killing, and studies have demonstrated the AUC/MIC, Cmax/MIC and t MIC ratios to be the best diviner of antibacterial effect. In the present study, based on the MIC values determined for selected antimicrobial agents, and pharmacokinetic parameters, amoxicillin, ceftiofur, cefquinome, enrofloxacin and florfenicol may be appropriate for the treatment of mastitis infections caused by susceptible Arcobacter spp. in buffaloes.
Article Details
- Comment citer
-
Altan, F., & Yesilmen Alp, S. (2022). Antimicrobial susceptibility testing of Arcobacter butzleri and Arcobacter cryaerophilus isolated from buffalo milk with subclinical mastitis: A different approach. Journal of the Hellenic Veterinary Medical Society, 73(2), 4227–4234. https://doi.org/10.12681/jhvms.27186
- Numéro
- Vol. 73 No 2 (2022)
- Rubrique
- Research Articles
Ce travail est disponible sous licence Creative Commons Attribution - Pas d’Utilisation Commerciale 4.0 International.
Authors who publish with this journal agree to the following terms:
· Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
· Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
· Authors are permitted and encouraged to post their work online (preferably in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.